Arkolith/Insider Trading/ENTX/Form 4

Toledano Miranda Jayne

Chief Executive Officer, DirectorEntera Bio Ltd. (ENTX) · full profile →Form 4 · filed Dec 30, 2025
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2025Buy(P)11K$1.81$20K427K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-25-004125) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML